Shenzhen Bioeasy Biotechnology Co., Ltd.

SZSE:300942.SZ

11.43 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Operating Activities:
Net Income 0000-7.111-85.749-29.526-41.571-28.061-65.399-3.04937.285114.12940.84632.35375.69887.6113.5412.7124.18435.03138.08713.072
Depreciation & Amortization 00007.10233.479-15.06111.61811.61830.36110.5177.0837.0837.9917.9915.9655.9655.3930.0412.38404.7361.042
Deferred Income Tax 00000080.202-65.14200-150.013150.01300000000000
Stock Based Compensation 000007.895-7.8877.887026.162-26.66526.66502.782000000000
Change In Working Capital 0000073.946-57.25557.2550-43.591176.678-176.6780-47.1363.696-63.6960-14.36231.84-70.2060-44.091-17.566
Accounts Receivables 0000024.713-12.73912.7390-29.25276.808-76.8080-38.91129.44-29.4405.9331.49-31.490-39.129-10.217
Change In Inventory 0000041.338-32.28432.2840-51.135126.677-126.6770-17.01934.183-34.1830-2.6164.4-45.0970-9.272-1.71
Change In Accounts Payables 00000000000000000000000
Other Working Capital 000007.895-12.23212.232036.797-26.80826.80808.80.073-0.0730-11.74627.4416.3804.31-15.856
Other Non Cash Items 0006.65116.524-0.53742.90612.175-37.548173.2137.86824.218-151.65725.133-9.09719.35717.73920.361-2.0880.676-55.7249.9551.188
Operating Cash Flow 0006.6519.41321.13913.38-17.778-53.991120.74515.33668.586-44.61157.98815.26589.09199.38524.93342.51317.037-20.68948.687-2.263
Investing Activities:
Investments In Property Plant And Equipment -16.142-66.774-37.945-33.375-36.009-39.938-23.204-48.445-17.057-56.378-76.553-24.707-19.21-27.829-28.647-10.95-12.08-32.618-30.737-11.44-8.041-2.803-20.991
Acquisitions Net 0.3590.079002.174.2840.646-86.7350.02000.15600000000000
Purchases Of Investments -1.80000-342-1.667-224.62500-97.5-573.2250-13.363610-6150000000
Sales Maturities Of Investments 1.7625.5140.286254.9880.187402.2410.398311.36001.280.9356.5663.5481.1360.4121.2083.4630.0325.4440.0382.761.954
Other Investing Activites 176.54129.281-127.214-337.8540.357-1209245.73541-10.111103.399526.828.6100-130-130-180310.042-309.999342-3420-75
Investing Cash Flow 160.72-31.9-164.873-116.242-33.652-155.65568.174-2.7123.963-66.489-69.374-70.04115.95662.355-157.511-140.538-190.872280.887-340.704336.004-350.003-0.044-94.036
Financing Activities:
Debt Repayment 1.96254.9-2.509-2.50948.72-22.56342.35447.139-0.087041.72000000-22002200
Common Stock Issued 0000000000000-20.38713.034-13.0340000000
Common Stock Repurchased 00000000000000000000000
Dividends Paid -1.545-1.031-1.856-1.235-1.215-8.498-1.004-10.122-0.582-0.519-0.314-99.8210-18.039-0.511-17.5280-0.354-0.354-44.997-0.003-70
Other Financing Activities 0.241.596-1.496-4.841-1.385-8.616-0.983-7.627-3.5510.374-5.594-89.5150-17.452-13.034-24.106182.706-0.426-0.151-0.649-0-0.423220
Financing Cash Flow 0.65655.465-5.861-8.58644.12-32.412340.36829.389-4.22-0.14635.812-89.5150-17.452-0.511-24.106182.706-22.071-0.505-45.64621.997-0.423220
Other Information:
Effect Of Forex Changes On Cash 1.7932.436-2.0082.354-1.2790.126-2.4668.396-1.135-12.5165.9985.736-0.027-3.1610.322-1.7490.086-9.495-2.051.35-0.083-0.957-0.451
Net Change In Cash 161.75444.377-171.774-113.795-148.2-166.802419.45617.297-35.38341.594-12.227-86.169-35.24896.183-143.57-77.71590.097274.254-300.746308.745-348.77847.264123.25
Cash At End Of Period 418.886257.132212.755386.556500.351481.749648.551229.095211.798247.181205.586217.813303.982339.23243.047386.617464.332374.23599.982400.72891.983440.761306.373